Genome Biologics
Genome Biologics identifies viable drug candidates and FDA approved drug repositioning compounds for Cardiovascular and Cardiometabolic disease. Capitalising on the power of our patented Artificial Intelligence (AI) driven preclinical multi-modality drug testing technology - We leverage the power of AI-based machine learning with transformative single cell in vitro and in vivo transgenesis to dramatically reduce the cost, time, and ethical burden of preclinical research in the pharmaceutical industry.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
3
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Genome Biologics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- LX
Lingling Xu
Computer Scientist · Information Technology
EmailPhone - JW
Jonathan Ward
CEO · General Business & Management
EmailPhone
Showing 2 of 4 verified contacts
Top roles at Genome Biologics
4 distinct titles indexed · top 4 shown.
- 1ceo
- 1computer scientist
- 1disease modelling lead
- 1head of research and drug discovery
Sign up to unlock all 4 contacts at Genome Biologics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Genome Biologics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.